Glofitamab + GemOx Superior to Rituximab + GemOx for Lymphoma
Significant overall survival benefit seen for Glofit-GemOx at primary and follow-up analysis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.